PCORI: Patient-Centered Outcomes Research Institute
PCORI is an independent, non-profit health research organization authorized by The Patient Protection and Affordable Care Act of 2010. PCORI funds and shares research that compares the clinical effectiveness of various choices that patients and healthcare providers have when selecting care. Please click on the following links for specific information regarding PCORI and funding opportunities.
2. PCORI PFA, Methodology Standards, and National Priorities
3. Patient and Stakeholder Engagement
4. Panel-Patient and Stakeholder Engagement
5. The Research Plan-PCORI's Approach to Open Science
6. Communicating Results and Planning for Dissemination
7. PCORI's Application Process
8. Q & A Day 1
9. PCORI's Authorizing Law and Mandates
10. Contract Award, Activation and Closeout
11. Panel-What Do PCORI Contracts Administrators Look For
12. Panel-Voices of Experience
13. Final Q&A and Day 2 Wrap-Up
14. PCORI_s Online Application System Training
PCORI Online - Common Issues Cheatsheet
Funding Opportunity with the Mountain West Consortium! We have a great opportunity for grant funding thru our association with the CTR-IN grant! Please see links and info below and contact us with any questions and if we can be of any service to you!
IDeA CTR-IN Grant Pilot study information
Clinical Translational Research defined:
Clinical research includes (1) patient-oriented research; (2) epidemiologic and behavioral studies; and (3) outcomes research and health services research.
Translational research (T1-T4) includes:
T1, Translation to Humans: Testing basic science discoveries in humans for clinical effect and/or applicability;
T2, Translation to Patients: Testing new interventions in human subjects under controlled environments to form the basis for clinical applications and evidence--based guidelines;
T3, Translation to Practice: Research on the application of new interventions or therapies in general practice; research that yields knowledge on best ways to implement new medical interventions in the clinic; and
T4, Translation to Population: Investigations of factors and/or interventions that influence the health of populations; ultimately results in improved health of the public.
Current Call for Applications
Please check back for information on Round 3 call!
Pilot Grant Coordinators:
Curtis Noonan, Ph.D.
Associate Professor of Epidemiology
Center for Environmental Health Sciences
University of Montana Missoula
C. William Shuttleworth, Ph.D.
Department of Neurosciences
University of New Mexico
Discovering new drugs using super computing
Computational chemist Danny Xu, Ph.D., talks about the role of molecular simulation and super computers in the the discovery of new drugs. He's a researcher in the College of Pharmacy at Idaho State University-Meridian Health Science Center.